A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Oncogene

• Publication date

  2005-11-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1208888PMID 16044155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs

  2005cited by this paper
• A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.

  2005cited by this paper
• A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress

  2005cited by this paper
• New apoptosis drugs face critical test

  2005cited by this paper
• XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

  2004cited by this paper
• Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells

  2004cited by this paper
• A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death

  2004influential reference
• Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

  2004cited by this paper
• A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.

  2004cited by this paper
• Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

  2004cited by this paper
• Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway.

  2003cited by this paper
• Apoptosis-targeted therapies for cancer.

  2003cited by this paper
• Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.

  2003cited by this paper
• Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells

  2003cited by this paper
• Direct activation of the apoptosis machinery as a mechanism to target cancer cells

  2003cited by this paper
• Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.

  2003cited by this paper
• IAP proteins: blocking the road to death's door

  2002cited by this paper
• Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ *

  2002cited by this paper
• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

  2001influential reference
• Structural basis for the inhibition of caspase-3 by XIAP.

  2001influential reference
• Structural basis of caspase-7 inhibition by XIAP.

  2001influential reference
• Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.

  2001influential reference
• The IAP family: endogenous caspase inhibitors with multiple biological activities

  2000cited by this paper
• Structural and biochemical basis of apoptotic activation by Smac/DIABLO

  2000cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Structural basis of IAP recognition by Smac/DIABLO

  2000influential reference
• Apoptosis and cancer chemotherapy

  2000cited by this paper
• Caspase-3 Is the Primary Activator of Apoptotic DNA Fragmentation via DNA Fragmentation Factor-45/Inhibitor of Caspase-activated DNase Inactivation*

  1999cited by this paper
• NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP

  1999influential reference
• Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

  1999cited by this paper
• IAP family proteins--suppressors of apoptosis.

  1999cited by this paper
• SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents

  1999cited by this paper
• Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound

  1997influential reference
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

  1980cited by this paper
• Cell death: the significance of apoptosis.

  1980cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper
• Shrinkage necrosis: A distinct mode of cellular death

  1971cited by this paper

• Pseudolaric acid B promotes lung cancer cells ferroptosis depending on JNK/ERK-mediated upregulation of survivin.

  2026cites this paper
• Synergistic effect of smac-mimetic and poly (I:C) on apoptosis of cholangiocarcinoma cells

  2023cites this paper
• Relative refractoriness of breast cancer cells to tumour necrosis factor‐α induced necroptosis

  2022influential citation
• Trailing TRAIL resistance in human breast adenocarcinoma cells with Trichostatin A and Zebularine.

  2022cites this paper
• Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer

  2020cites this paper
• Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy

  2020cites this paper
• Epigallocatechin-3-Gallate Induces Apoptosis as a TRAIL Sensitizer via Activation of Caspase 8 and Death Receptor 5 in Human Colon Cancer Cells

  2020cites this paper
• Sensitization of pancreatic carcinoma cells for chemotherapy-induced apoptosis using small-molecule inhibitors of X-linked inhibitor of apoptosis protein (XIAP)

  2020cites this paper
• The Mitochondrion as an Emerging Therapeutic Target in Cancer.

  2020cites this paper
• Inactivation of SAG or ROC1 E3 Ligase Inhibits Growth and Survival of Renal Cell Carcinoma Cells: Effect of BIM

  2019cites this paper
• Smac Gene Delivery by the Glycol Chitosan with Low Molecular Weight Polyethylenimine Induces Apoptosis of Cancer Cells for Combination Therapy with Etoposide

  2019cites this paper
• CYP1B1 prevents proteasome-mediated XIAP degradation by inducing PKCε activation and phosphorylation of XIAP.

  2019cites this paper
• Eukaryotic initiation factor 5B (eIF5B) provides a critical cell survival switch to glioblastoma cells via regulation of apoptosis

  2019cites this paper
• The TRAIL to cancer therapy: Hindrances and potential solutions.

  2019cites this paper
• Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)

  2017cites this paper
• IAPs and Resistance to Death Receptors in Cancer

  2017cites this paper
• Small molecules as activators in medicinal chemistry (2000–2016)

  2017cites this paper
• Biological determinants of radioresistance and their remediation in pancreatic cancer.

  2017cites this paper
• Therapeutic opportunities based on caspase modulation.

  2017cites this paper
• Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.

  2017cites this paper
• Stem Cell Regulation by Death Ligands and Their Use in Cell Therapy

  2017cites this paper
• Targeted induction of apoptosis for cancer therapy C ha pt er 2

  2017cites this paper
• Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine

  2017cites this paper
• Smac Mimetics to Therapeutically Target IAP Proteins in Cancer.

  2017cites this paper
• Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis

  2016cites this paper
• IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα

  2016cites this paper
• ACTIVITY OF MONOMERIC SECOND MITOCHONDRIAL ACTIVATOR OF CASPASES (SMAC) MIMETIC COMPOUNDS ON HUMAN FIBROBLAST-LIKE SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS

  2016cites this paper
• Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6

  2016cites this paper
• Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle

  2015cites this paper
• Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1

  2015cites this paper
• Smac mimetics as IAP antagonists.

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion

  2015cites this paper
• Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization

  2015cites this paper
• Small-molecule SMAC mimetics as new cancer therapeutics.

  2014cites this paper
• DEPTOR has growth suppression activity against pancreatic cancer cells

  2014cites this paper
• Tailoring Peptidomimetics for Targeting Protein–Protein Interactions

  2014cites this paper
• Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10

  2014cites this paper
• Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity

  2014cites this paper
• Suppression of tumor angiogenesis by targeting the protein neddylation pathway

  2014cites this paper
• Cellular Inhibitor of Apoptosis (cIAP)-Mediated Ubiquitination of Phosphofurin Acidic Cluster Sorting Protein 2 (PACS-2) Negatively Regulates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Cytotoxicity

  2014cites this paper
• Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors.

  2014cites this paper
• Molecular Pathways Molecular Pathways : Targeting Death Receptors and Smac Mimetics

  2014cites this paper
• Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma.

  2014cites this paper
• Untersuchung der Wirkung des Inhibitor of Apoptosis Antagonisten BV6 auf primäre CLL Zellen

  2014cites this paper
• Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

  2014cites this paper
• Novel Role of CHK2 in the Intrinsic and Extrinsic Apoptosis Pathway

  2014cites this paper
• Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis.

  2013cites this paper
• Human Cancer Resistance to Trail-Apoptotic Pathway-Targeted Therapies

  2013cites this paper
• Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy

  2013cites this paper
• Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis

  2013cites this paper
• The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells

  2013cites this paper
• Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging

  2013cites this paper
• Lentiviral vectors: a versatile tool to fight cancer.

  2013cites this paper
• Tat-SmacN 7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis

  2013cites this paper
• Enhanced cell death imaging using multivalent zinc(II)-bis(dipicolylamine) fluorescent probes.

  2013cites this paper
• Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.

  2013cites this paper
• Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis

  2012cites this paper
• Smac: Its role in apoptosis induction and use in lung cancer diagnosis and treatment.

  2012cites this paper
• Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy.

  2012cites this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cites this paper
• Identification of a novel protein kinase Cδ–Smac complex that dissociates during paclitaxel‐induced cell death

  2012cites this paper
• In Vivo Optical Imaging of Cell Death Using Fluorescent Synthetic Coordination Complexes

  2012cites this paper
• Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco

  2012cites this paper
• Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells

  2012cites this paper
• The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme

  2012cites this paper
• Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis

  2012cites this paper
• Targeting Inhibitors of Apoptosis Proteins (IAPs) For New Breast Cancer Therapeutics

  2012cites this paper
• Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

  2011cites this paper
• X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma

  2011cites this paper
• Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.

  2011cites this paper
• Investigation of TRAIL resistance in ovarian cancer cell lines and translational application in primary ovarian cancer cells

  2011cites this paper
• Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases

  2011cites this paper
• Screening multicomponent reactions for X-linked inhibitor of apoptosis-baculoviral inhibitor of apoptosis protein repeats domain binder.

  2011cites this paper
• Clinical significance of Smac expression on non-small cell lung cancers

  2011cites this paper
• Identification of novel therapeutic targets in mastocytosis:Inhibition of survival of neoplastic mast cells by targeting IAPs and TRAIL receptors

  2011cites this paper
• Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.

  2011cites this paper
• Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.

  2011cites this paper
• Targeting Apoptosis Signaling Pathways for Anticancer Therapy

  2011cites this paper
• Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment

  2011cites this paper
• Targeting p53 for Novel Anticancer Therapy 1

  2010cites this paper
• Protein Kinase C as an Apoptosis Regulator and a Potential Prognostic Marker in Breast Cancer

  2010cites this paper
• Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner

  2010cites this paper
• Expressionsprofil und prognostische Bedeutung der mitochondrialen IAP Antagonisten Smac/DIABLO und Omi/HtrA2 im klarzelligen Nierenzellkarzinom

  2010cites this paper
• Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist

  2010cites this paper
• IAP and death receptors-targeted therapies in bladder cancer

  2010cites this paper
• A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)‐induced invasion and metastasis of cholangiocarcinoma cells

  2010cites this paper
• Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.

  2010cites this paper
• Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kappaB activation in mouse embryonic stem cells.

  2010cites this paper
• Rhabdastrellic Acid-A Induced Autophagy-Associated Cell Death through Blocking Akt Pathway in Human Cancer Cells

  2010cites this paper
• Targeting p53 for Novel Anticancer Therapy.

  2010cites this paper
• IAP antagonists: promising candidates for cancer therapy.

  2010cites this paper
• Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells

  2010cites this paper
• Correction: Positive Cross-Talk between Estrogen Receptor and NF-κB in Breast Cancer

  2010cites this paper
• Design of small-molecule Smac mimetics as IAP antagonists.

  2010cites this paper
• Protein Kinase C as an Apoptosis Regulator and a Potential Prognostic Factor in Breast Cancer

  2010cites this paper
• Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target

  2010cites this paper
• Caspase-9 Activation by the Apoptosome Is Not Required for Fas-mediated Apoptosis in Type II Jurkat Cells*

  2009cites this paper
• A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB

  2009cites this paper
• Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.

  2009cites this paper